What Conscio Group does

Conscio Group is a Munich-headquartered scientific service provider that has operated GMP/GCP/GLP and FDA-certified laboratories across five European countries for over 25 years. The company employs approximately 500 professionals across ten certified sites in Germany, Czech Republic, Austria, Slovakia, and Italy, serving pharmaceutical, food, and industrial customers with regulated testing, development, and certification services. Its current holding structure, Conscio Holding GmbH (HRB 265657, Amtsgericht Munchen), is backed by BBA Capital Partners under a Family Equity ownership model.

The firm operates three integrated divisions. Conscio Pharma delivers formulation development, analytical R&D, GMP-compliant investigational medicinal product manufacturing in a 1,340 m^2 facility, Phase I clinical trials across 96 combined beds in Prague and Ostrava, bioanalytical testing at 3,750 samples/day throughput, biologics and biosimilars characterization, batch release testing under QP certification, and microbiology. Technical infrastructure includes HPLC/UPLC, LC-MS/MS (QqQ and ion trap), LC-FTMS, GC with FID/MS/ECD, ICP-MS, capillary and gel electrophoresis, IEF/cIEF, automatic amino acid analysis, ELISA, ECLA, cell-based assays, plus a 500 m^2 laboratory dedicated to highly potent APIs and 250 m^3 ICH-compliant stability storage. Conscio Food delivers EN ISO/IEC 17025-accredited chemical, microbiological, molecular, and sensory testing, EN ISO/IEC 17065 certification (IFS, organic AT-BIO-901, ISO 22000, RSPO, MSC/ASC, V-Label), inspection services, and on-site rapid ATP-based hygiene monitoring products. Conscio Sustainability provides environmental testing for water, soil, air, and odour, plus industrial testing of cosmetics, waste, fuels, plastics, and workplace environments.

Revenue is generated through enterprise B2B contracts under quote-based, multi-year engagements with pharmaceutical innovators, generic manufacturers, vaccine producers, biotech firms, food processors, and governmental/industrial customers. The go-to-market blends direct enterprise sales with scientific thought leadership: CPHI presence (Frankfurt 2025, Milan 2024), hosted scientific conferences, webinars, white papers, and regulatory commentary. No standardized public pricing is offered; customer relationships described in publicly available testimonials show 10-year-plus durations, indicating sticky integration of method validations and regulatory batch-release workflows rather than transactional volume selling.

Name

Conscio Group

Legal name

Conscio Holding GmbH

Website

https://consciogroup.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Conscio Group is a Munich-headquartered scientific services provider operating GMP/GCP/GLP/FDA-certified laboratories across five European countries, delivering pharmaceutical development, clinical trials, bioanalytical testing, food safety analysis, certification, and environmental testing to enterprise clients.

Ownership category

akta.pro rank

Product category

Contract Laboratory Services

NAICS

Other Scientific and Technical Consulting Services (54169), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA) (AFALADAC)

Keywords

• Contract laboratory services
• Pharmaceutical analytical testing
• GMP-certified testing
• Bioanalytical research services
• Clinical trial services

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Laboratory Services: Comprehensive analytical services for pharmaceutical companies across drug development lifecycle including formulation development, analytical R&D, IMP manufacturing, clinical trials, bioanalytical testing, batch release testing, pharmaceutical analyses, biologics/biosimilars analysis, and microbiology testing. Services are GMP/GLP/GCP certified and FDA/EMA inspected.
2. Food Testing and Certification Services: EN ISO/IEC 17025-accredited laboratory testing covering chemical, microbiological, molecular, and sensory analyses for food products. Includes certification services (IFS, Organic, ISO 22000, ISO 9001, sustainability standards), inspection services, and LVA Academy training programs.
3. Environmental and Industrial Testing Services: Environmental testing for water, soil, air quality including physical, chemical, microbiological, and molecular analyses. Industrial testing for cosmetics, waste, fuels, plastics, workplace environments. Odour analysis using dynamic olfactometry.
4. On-Site Testing Solutions: Distribution of rapid hygiene and microbiological monitoring technologies including Lumitester Smart, rapid ATP detection systems, chromogenic media, and certified test textiles for surface cleaning validation. Products validated for hygiene and food safety applications.
5. Consulting and Expert Services: Regulatory consulting for EMA/FDA compliance, nitrosamine risk assessment, extractables and leachables studies, stability study design, and technical transfer services. Advisory services on food law, labelling, and advertising claims.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Conscio Group is a European scientific service provider operating GMP/GCP/GLP and FDA-certified laboratories across Germany, Czech Republic, Austria, Slovakia, and Italy, serving pharmaceutical, food, and sustainability industry clients. Through its three divisions — Conscio Pharma, Conscio Food, and Conscio Sustainability — the company delivers formulation development, IMP manufacturing, clinical trials, bioanalytical testing, biologics/biosimilars characterization, batch release testing, pharmaceutical analysis, microbiology, food testing/certification/inspection, and environmental/industrial testing on a project and contract basis.

Product overview

Conscio Group is a scientific service provider operating three integrated divisions: Conscio Pharma, Conscio Food, and Conscio Sustainability. The company provides end-to-end laboratory and testing services rather than a unified software platform. Conscio Pharma offers formulation development, analytical R&D, IMP manufacturing, clinical trials, bioanalytical testing, pharma analysis, biologics/biosimilars services, batch release testing, and microbiology across GMP/GLP/GCP certified facilities. Conscio Food delivers food testing, certification (IFS, organic, ISO standards), inspection services, and on-site rapid hygiene testing solutions. Conscio Sustainability provides environmental testing (water, odour, molecular biology) and industrial product testing. With approximately 500 professionals across 10 certified sites in Germany, Czech Republic, Austria, Slovakia, and newly Italy, the company handles over 38,000 samples annually and conducts more than 1,000 audits. Services span from early R&D through commercial release, with regulatory expertise covering EU, FDA, and international standards.

Differentiator

Problem solved

Functional benefit

Brands

• Conscio Pharma: Pharmaceutical services including formulation development, analytical R&D, IMP manufacturing, clinical trials, bioanalytical testing, pharma analysis, biologics and biosimilars, batch release testing, and microbiology.
• Conscio Food
• Conscio Sustainability

Products and services

• Formulation Development Comprehensive pharmaceutical formulation development from early feasibility through clinical supply, covering solubility enhancement, drug delivery solutions, and broad dosage form capabilities including solid, liquid, semi-solid, and specialized transdermal systems. Service is delivered to pharmaceutical companies and biotech firms via Conscio's GMP-certified laboratories.
• Analytical R&D Pharmaceutical analytical research and development support including analytical method development, impurity identification, degradation and stability studies, trace analyses, nitrosamines testing, extractables and leachables studies, and IVRT/IVPT method development. Service targets pharmaceutical development teams.
• IMP Manufacturing GMP-compliant investigational medicinal product manufacturing in a 1,340 m² facility for Phase I, II, pilot, and bioequivalence studies. Capabilities include hard capsules, granules, powders, pellets, oral dispersible films, tablets (uncoated and coated), transdermal systems, and solutions. Service supports clinical trial supply for pharmaceutical sponsors.
• Clinical Trials Early-phase clinical trial services including Phase I/II studies, bioequivalence and pharmacokinetic research. Combined 96-bed capacity across two clinical units in Czech Republic (Prague 60 beds + Ostrava 36 beds), with full GCP/GLP compliance and integrated bioanalytical and biostatistics support. Target customers are pharmaceutical and generic drug manufacturers.
• Bioanalytical Testing Analytical services from pre-clinical through Phase III studies including method development and validation (450+ methods to date), PK/TK studies, drug and metabolite analysis, and full statistical evaluation. Capacity of 3,750 biological samples per day using HPLC/MS/MS systems with Hamilton robotic sample preparation. Targets pharmaceutical companies conducting clinical studies.
• Pharma Analysis GMP-quality testing for pharmaceutical development, manufacturing, and quality control including method validation, routine QC testing, stability studies (approximately 100 new stability studies annually), and testing of highly potent substances in a dedicated 500 m² laboratory facility. Targeted at pharmaceutical manufacturers requiring regulated QC and stability programs.
• Biologics and Biosimilars Comprehensive biopharmaceutical analytical services including post-production characterization (SoloVPE, Maurice, capillary electrophoresis, gel electrophoresis, IEF/cIEF, automatic amino acid analysis, LC-FTMS, UHPLC-MS/MS QqQ and ion trap), potency assessment, quantification in biological matrices using LC-MS and LBA methods, immunogenicity testing, PK analysis, and plasma protein binding studies. Service is compliant with EMA, FDA, and ICH guidelines and targets biologics manufacturers and biosimilars developers.
• Batch Release Testing & QP Certification GMP-compliant batch release testing and Qualified Person (QP) certification mandatory for EU market entry of medicinal products. Covers analytical method implementation, QC testing, and stability storage (250 m³ capacity). Service is required by pharmaceutical companies seeking EU commercial release.
• Microbiology Standard microbiology quality tests for pathogen identification, hygiene and spoilage parameters, supported by chemical and microscopic analyses. Includes molecular biology techniques for allergen, GMO, and pathogen detection using ELISA and PCR methods. Targets pharmaceutical manufacturing, food production, and related regulated industries.
• Food Testing EN ISO/IEC 17025-accredited laboratory testing covering chemical, microbiological, molecular, and sensory analyses for raw materials, processed products, packaging, and food supplements, plus inspection and certification support. Designed for food producers, retailers, and food service operators needing regulatory compliance and quality assurance.
• Certification Accredited certification body (EN ISO/IEC 17065) providing IFS standards (IFS Food, Broker, Logistics, Wholesale/Cash & Carry, Progress), organic certification (AT-BIO-901 covering BIO Austria, Demeter, AMA Bio Siegel, Prüf Nach!), HACCP audits, GMP audits, ISO 22000/9001 (in cooperation with TÜV Austria), sustainability standards (MSC, ASC, RSPO, UTZ via Control Union Germany), and V-Label certification for vegetarian and vegan products. Service targets food industry companies needing third-party accredited certification.
• Inspection Food safety inspection services covering hygiene audits, business operations inspections, product sampling, and environmental sampling (swab samples, water samples, airborne bacterial count) across food production and catering facilities. Targets food manufacturers, retailers, and food service operators requiring independent inspection and audits (over 1,000 audits annually).
• On-Site Testing Solutions Rapid hygiene and microbiological monitoring solutions delivered directly at point of need, featuring ATP-based detection technology (Lumitester Smart with patented A3 technology detecting ATP, ADP, and AMP), digital reporting, and ready-to-use swab kits for real-time hygiene verification across single or multi-site food safety and HACCP-compliant operations. Includes distribution of rapid ATP detection systems, chromogenic media, and certified test textiles.
• Industrial Testing Physical, chemical, and microbiological analyses for industrial products including cosmetics, waste, fuels, plastics, and workplace environments, ensuring compliance with applicable standards. Service targets industrial companies and manufacturers requiring quality and regulatory testing of products and processes.
• Environmental Testing Water analysis (drinking, raw, underground, surface, wastewater), odour analysis using dynamic olfactometry, molecular biology PCR-based pathogen detection, and consulting services conducted in ISO/IEC 17025 accredited laboratories. Designed for industrial companies, governmental institutions, and environmental agencies requiring compliance testing.
• LVA Academy Training Programs Knowledge transfer and training programs for food processing, food safety, and regulatory compliance, ISO 21001:2018 certified, located at Conscio's Austrian facility. Target audience includes food industry professionals, auditors, and quality personnel.

Quantifiable outcome

• Over 780 biostudies successfully completed for pharmaceutical companies across Europe, US, Asia, and Australia
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Paras Biopharmaceuticals Finland OycoreStrategic or Co-development Partner · 1 June 2026Development and registration partnership signed for PBR-401, a biosimilar candidate of romiplostim. Conscio Group will carry out clinical and analytical work program for EMA and FDA registration. Paras contributes the product and proprietary microbial production technology. Programme draws on Conscio's in-house clinical units and EMA/FDA-inspected laboratories in Czech Republic.
• SigutLabsminorStrategic or Co-development Partner · 23 March 2026Joint webinar collaboration on ADC Performance by Design exploring linker chemistry, DAR control, and bioanalytical strategies. SigutLabs contributes chemistry expertise (Head of Chemistry Alessandro Panattoni) while Conscio provides integrated analytical and bioanalytical perspectives.
• Kiel LaboratoriescoreStrategic or Co-development Partner · 2 October 2024Conscio Group and Kiel Laboratories announced strategic partnership in October 2024. Kiel Laboratories, Inc. is a leading U.S. pharmaceutical research company. The partnership connects Conscio's European GMP/GLP/GCP/IEC-certified contract R&D service network with Kiel's U.S. pharmaceutical research capabilities.
• Reference Analytics GmbHminorStrategic or Co-development Partner · 14 May 2024Conscio Group expanded its range of services in Austria by acquiring Reference Analytics GmbH. This acquisition strengthened Conscio's analytical service offerings in the Austrian market.
• Control Union GermanyminorChannel Partner/ Reseller/ DistributorPartnership for RSPO sustainable palm oil certification, Rainforest Alliance certification, and MSC/ASC sustainable fishing/aquaculture certification. Control Union Germany provides certification services in cooperation with Conscio.
• TÜV AustriaminorChannel Partner/ Reseller/ DistributorPartnership for ISO certification services including ISO 22000 (food safety management systems) and ISO 9001 (quality management systems) conducted in cooperation with TÜV Austria.

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Celerion: Private, Lincoln (US)-headquartered early-phase clinical and bioanalytical CRO. Highly comparable to Conscio on Phase I clinical capacity, bioanalytical method development, and PK/bioequivalence focus.
• SGS SA: Swiss global testing, inspection and certification company with a sizable life-sciences and food/health testing portfolio. Comparable to Conscio's food testing, certification, and pharma quality services.
• Eurofins Scientific: Luxembourg-headquartered global leader in bioanalytical, food, environmental and pharmaceutical testing services. Directly comparable to Conscio across pharma testing, food safety and environmental analysis, with a far larger European lab network.
• Bureau Veritas: French global testing, inspection and certification (TIC) company. Comparable to Conscio on food testing, environmental testing, and certification services, with broader industrial and commodity focus.
• Intertek Group: UK-based testing, inspection and certification provider with pharmaceutical, food and environmental service lines. Closely comparable business model and end-market overlap with Conscio's three divisions.
• QPS Holdings: US-based bioanalytical and clinical CRO with European operations (including the Netherlands and Austria). Closely comparable to Conscio on GLP bioanalytical, PK studies, and bioequivalence services.
• Charles River Laboratories: US-headquartered CRO with strong bioanalytical, biologics characterization and early-phase clinical capabilities. Overlaps with Conscio's bioanalytical, biologics/biosimilars, and clinical testing services.

Broad incumbents

• ICON plc: Ireland-based global clinical CRO with bioanalytical and central lab capabilities. Comparable to Conscio's clinical and central lab services as part of a much broader, full-service offering.
• IQVIA: Largest global clinical CRO and life-sciences data company. Overlaps with Conscio's clinical trials and bioanalytical services but operates at vastly larger scale and with broader technology and data offerings.

Emerging players

• Nuvisan Pharma Services: Germany-based European CRO/CDMO with bioanalytical, clinical and small-molecule development capabilities. Comparable European-headquartered, mid-sized peer with overlapping pharma testing and bioanalytical services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCgY_vzhjjQIkYB8ZczXP30g
• LinkedInlinkedin.com/company/conscio-group

Compliance26 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conscio Group